Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Cynosure Inc

BioPhotonics
Mar 2012
Cynosure Inc. of Westford, Mass., has announced that the FDA has cleared its Cellulaze cellulite laser workstation for commercial distribution. The workstation provides a minimally invasive solution for reducing cellulite in just one treatment by restoring the normal structure of the skin and underlying connective tissue. Clinical data has demonstrated that the treatment can increase the thickness of the skin by 25 percent and elasticity by 29 percent at one year.

AmericasBiophotonicsBusinessCellulazeCellulaze cellulite laser workstationCynosureFDAlaser-based aesthetic treatmentlaser-based cellulite treatmentlaser-based cosmetic treatmentlaser-based skin treatmentlasersMassachusettsRapidScanU.S. Food and Drug Administration

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!